| For: | Sanceau J, Gougelet A. Epigenetic mechanisms of liver tumor resistance to immunotherapy. World J Hepatol 2021; 13(9): 979-1002 [PMID: 34630870 DOI: 10.4254/wjh.v13.i9.979] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v13/i9/979.htm |
| Number | Citing Articles |
| 1 |
Seyed Mohammadmahdi Meybodi, Bahareh Farasati Far, Ali Pourmolaei, Farid Baradarbarjastehbaf, Maryam Safaei, Niloufar Mohammadkhani, Ali Akbar Samadani. Immune checkpoint inhibitors promising role in cancer therapy: clinical evidence and immune-related adverse events. Medical Oncology 2023; 40(8) doi: 10.1007/s12032-023-02114-6
|
| 2 |
Maria Rita Braghini, Oriana Lo Re, Ilaria Romito, Maite G. Fernandez-Barrena, Barbara Barbaro, Silvia Pomella, Rossella Rota, Manlio Vinciguerra, Matias A. Avila, Anna Alisi. Epigenetic remodelling in human hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02297-2
|
| 3 |
Linda Galasso, Lucia Cerrito, Valeria Maccauro, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco. Inflammatory Response in the Pathogenesis and Treatment of Hepatocellular Carcinoma: A Double-Edged Weapon. International Journal of Molecular Sciences 2024; 25(13) doi: 10.3390/ijms25137191
|
| 4 |
Jose J. G. Marin, Rocio I. R. Macias, Maitane Asensio, Marta R. Romero, Alvaro G. Temprano, Olívia R. Pereira, Silvia Jimenez, Jose L. Mauriz, Silvia Di Giacomo, Matias A. Avila, Thomas Efferth, Oscar Briz. Strategies to enhance the response of liver cancer to pharmacological treatments. American Journal of Physiology-Cell Physiology 2024; 327(1) doi: 10.1152/ajpcell.00176.2024
|
| 5 |
Jiaojiao Zheng, Siying Wang, Lei Xia, Zhen Sun, Kui Ming Chan, René Bernards, Wenxin Qin, Jinhong Chen, Qiang Xia, Haojie Jin. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduction and Targeted Therapy 2025; 10(1) doi: 10.1038/s41392-024-02075-w
|
| 6 |
Jianing Wang, Shida Pan, Chuyue Xiong, Jiahe Tian, Yilin Wang, Yingying Yu, Siyu Wang, Yingjuan Shen, Luo Yang, Xiaomeng Liu, Junqing Luan, Mengdie Jia, Xuanxuan Duan, Fusheng Wang, Fanping Meng. Elevated IL-17A level is associated with poor overall survival following immune checkpoint inhibitors combined with targeted therapy in hepatocellular carcinoma with hyperbilirubinemia. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1791538
|
| 7 |
Francesca Salani, Virginia Genovesi, Caterina Vivaldi, Valentina Massa, Silvia Cesario, Laura Bernardini, Miriam Caccese, Jessica Graziani, Dario Berra, Lorenzo Fornaro, Gianluca Masi. Primary Resistance to Immunotherapy-Based Regimens in First Line Hepatocellular Carcinoma: Perspectives on Jumping the Hurdle. Cancers 2022; 14(19) doi: 10.3390/cancers14194896
|
| 8 |
Giulia Francesca Manfredi, Ciro Celsa, Chloe John, Charlotte Jones, Nicole Acuti, Bernhard Scheiner, Claudia Angela Maria Fulgenzi, James Korolewicz, Matthias Pinter, Alessandra Gennari, Francesco Mauri, Mario Pirisi, Rosalba Minisini, Federica Vincenzi, Michela Burlone, Cristina Rigamonti, Matteo Donadon, Giuseppe Cabibbo, Antonio D'Alessio, David James Pinato. Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2023; doi: 10.2147/JHC.S291553
|
| 9 |
Elias Kouroumalis, Ioannis Tsomidis, Argryro Voumvouraki. Is There a Place for Somatostatin Analogues for the Systemic Treatment of Hepatocellular Carcinoma in the Immunotherapy Era?. Livers 2022; 2(4) doi: 10.3390/livers2040024
|